MTHFR C677T polymorphism and colorectal cancer risk in asians, a meta-analysis of 21 studies

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1203-1208

  Yang, Zhen ^a   Zhang, Xie Fu ^a   Liu, Hong Xiang ^a   Yong Shun, ^a   Hao, ^a   Zhao, Chun Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Analysis; Colorectal cancer; Meta; MTHFR C677T; Polymorphism

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ALLELE; ARTICLE; ASIAN; BLOOD; COLORECTAL TUMOR; CONFIDENCE INTERVAL; DIET; GENETICS; HUMAN; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DIET; FOLIC ACID; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873039948     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1203     Document Type: Article

References (38)

1. AT (1999). Assessing the influence of a single study in the metaanalysis estimate. Stata Tech Bull, 8, 15-7.
2. Cao HX, Gao CM, Takezaki T, et al (2008). Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev, 9, 203-8.
3. Chang SC, Lin PC, Lin JK, et al (2007). Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis, 22, 483-9.
4. Cui LH, Shin MH, Kweon SS, et al (2010). Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer, 10, 236.
5. Der Simonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
6. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
7. Egger M, Smith GD, Phillips AN (1997). Meta-analysis, principles and procedures. BMJ, 315, 1533-7.
8. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease, a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
9. Goyette P, Sumner JS, Milos R, et al (1994). Human methylenetetrahydrofolate reductase, isolation of cDNA, mapping and mutation identification. Nat Genet, 7, 195-200.
10. Hao L, Tian Y, Zhang F, et al (2002). Variation of plasma folate levels in adults between some areas and different seasons in China]. Zhonghua Yu Fang Yi Xue Za Zhi, 36, 308.
11. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
12. Huang P, Zhou ZY, Ma HT, et al (2003). MTHFR polymorphisms and colorectal cancer susceptibility in Chongging people. Acta Academiae Med Militaris Tertiae, 25, 1710-5.
13. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
14. Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
15. Jiang DK, Ren WH, Yao L, et al (2010). Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology, 76, 765 e1-7.
16. Jiang DK, Wang WZ, Ren WH, et al (2011). TP53 Arg72Pro polymorphism and skin cancer risk, a meta-analysis. J Invest Dermatol, 131, 220-8.
17. Jiang Q, Chen K, Ma X, et al (2005). Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev, 29, 146-54.
18. Jiang QT, Chen K, Ma XY, et al (2004). A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 25, 612-6.
19. Jin XX, Zhu ZZ, Wang AZ, et al (2007). Association of methylenetetrahydrofoIate reductase C677T polymorphism with genetic susceptibility to colorectal cancer. Shijie Huaren Xiao Hua Za Zhi, 15, 2754-7.
20. Kang BS, Ahn DH, Kim NK, et al (2011). Relationship between metabolic syndrome and MTHFR polymorphism in colorectal cancer. J Korean Soc Coloproctol, 27, 78-82.
21. Kim DH, Ahn YO, Lee BH, et al (2004). Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett, 216, 199-205.
22. Kim J, Cho YA, Kim DH, et al (2012). Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr, 95, 405-12.
23. Kim JW, Park HM, Choi YK, et al (2011). Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients. Oncol Rep, 25, 167-72.
24. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
25. Markowitz SD, Bertagnolli MM (2009). Molecular origins of cancer, Molecular basis of colorectal cancer. N Engl J Med, 361, 2449-60.
26. Matsuo K, Hamajima N, Hirai T, et al (2002). Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev, 3, 353-9.
27. Matsuo K, Ito H, Wakai K, et al (2005). One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis, 26, 2164-71.
28. Miao XP, Yang S, Tan W, et al (2005). Association between genetic variations in methylenetetrahydrofolate reductase and risk of colorectal cancer in a Chinese population. Zhonghua Yu Fang Yi Xue Za Zhi, 39, 409-11.
29. Otani T, Iwasaki M, Hanaoka T, et al (2005). Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer, 53, 42-50.
30. Park KS, Mok JW, Kim JC (1999). The 677C > T mutation in 5, 10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test, 3, 233-6.
31. Promthet SS, Pientong C, Ekalaksananan T, et al (2010). Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. J Epidemiol, 20, 329-38.
32. Stuck AE, Rubenstein LZ, Wieland D (1998). Bias in metaanalysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469; author reply 70-1.
33. Thompson SG, Higgins J (2002). How should meta-regression analyses be undertaken and interpreted? Stat Med, 21, 1559-73.
34. Yang XX, Li FX, Yi JP, et al (2010). Association of MTHFR C677T polymorphism and susceptibility of lung cancer, gastric cancer and colorectal cancer risk. Guangdong Yi Xue, 31, 2375-8.
35. Yin G, Kono S, Toyomura K, et al (2004). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer, the Fukuoka Colorectal Cancer Study. Cancer Sci, 95, 908-13.
36. Zhang YL, Yuan XY, Zhang C, et al (2008). Relationship between polymorphisms of thymidylate synthase and methylenetetrahydrofolate reductase and susceptibility in Liaoning Benxi colorectal cancer pafients. Linchuang Zhong Liu Xue Za Zhi, 13, 769-74.
37. Zhu F, Wang YM, Zhang QM (2010). A case-control study of plasma homocysteine, serum folate, the polymorphism of methylenetetrahydrofolate reductase in colorectai cancer. Dongnan Da Xue Xue Bao, 29, 88-92.
38. Zhu Q, Jin Z, Yuan Y, et al (2011). Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer. Scand J Gastroenterol, 46, 436-45.